Showing results (101-110 of 233) with videos related to

Sort By:
Pageof 24
Hypertension (Dallas, Tex. : 1979)|September 18, 1999
Sympathoinhibitory function of the alpha(2A)-adrenergic receptor subtypeK P Makaritsis, C Johns, I Gavras, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1982
Evidence for a sodium-induced activation of central neurogenic mechanisms in one-kidney, one-clip renal hypertensive ratsB Waeber, H Gavras, I Gavras, et al.
Journal of Clinical Hypertension|December 1, 1987
Double-blind, placebo-controlled trial of twice-daily nifedipine as a step-2 agent in mild essential hypertensionL P Svetkey, M H Weinberger, H Gavras, et al.
Journal of Human Hypertension|January 10, 2014
Differential gene expression of bradykinin receptors 1 and 2 in peripheral monocytes from patients with essential hypertensionM E Marketou, J Kontaraki, E Zacharis, et al.
Clinical Science (London, England : 1979)|December 1, 1981
Effects of the oral angiotensin-converting enzyme inhibitor MK-421 in human hypertensionH Gavras, J Biollaz, B Waeber, et al.
British Journal of Clinical Pharmacology|January 1, 1979
Orally active angiotensin-converting enzyme inhibitor (SO 14,225) as a treatment for essential hypertensionH R Brunner, H Gavras, B Waeber, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|October 9, 1998
Chronic sympathetic suppression in the treatment of chronic congestive heart failureA J Manolis, C Olympios, M Sifaki, et al.
Annals of Internal Medicine|January 1, 1979
Converting enzyme inhibition in hypertensive emergenciesC P Tifft, H Gavras, G R Kershaw, et al.
Hypertension (Dallas, Tex. : 1979)|July 1, 1981
Role of reactive hyperreninemia in blood pressure changes induced by sodium depletion in patients with refractory hypertensionH Gavras, B Waeber, G R Kershaw, et al.
Pageof 24